RxDoctor Payments Data

Sammy Becdach

Hematology & Oncology · Decatur, ALNPI 1497726137

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.8% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,440 and has fallen 99.4% since, to $16 in 2023. That places this record below the midpoint for hematology & oncology clinicians in AL, where the typical reported total is $7,159.

$3,890in general payments, 2019–2025

Across 246 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$412
  • Novartis$357
  • Merck$347
  • Johnson & Johnson$329
  • Pfizer$275
  • E.r. Squibb & Sons, L.L.C.$270
  • plus $2K from 38 others

What the payments were for

  • Speaking & faculty fees$1554%
  • Food & beverage$3,53391%
  • Education$2015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,890 in reported general payments places this provider in the 35th percentile of 177 hematology & oncology providers in Alabama.

See all hematology & oncology providers in Alabama →

Other hematology & oncology in Decatur

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →